Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
But it will continue to rise as long as oil goes up as it has over the last year. And as the world starts up again oil will rise.
When oil starts to descend then you sell. Yes long term holders will lose eventually, but it is still a valuable weapon to use. IMO
But continued good luck to you and to myself when we flip and.
I agree about flipping and what I do.
LOL I know the feeling
Out of posts. Ok about next week. Guess we were both wrong? LOL Stuck in neutral.
I hope you held on and got the TRIPLE?
TRIPLED since your post and check all the ratings on the holdings like Exxon.
TRIPLED since Oct. '20.
Is it a good thing? LOL Not sure what that means?
Yeah
Ok LOL
Yes let's see.
Charts saying $1.50 (then breakout to $2.00?)
TTOO - "T2 Biosystems shares are trading higher after the company reported better-than-expected Q1 sales results."
TTOO - charts saying $1.50 (& breakout to $2.00?)
Average now $31.93. Good entry?
In at $35.42. Too high? Too late?
MITO moving up 63% pm
MITO today: https://cnafinance.com/stealth-biotherapeutics-mito-stock-flies-on-data/
"The bottom line here is simple, Stealth BioTherapeutics may be onto something big here."
NICE quote
MITO may be winner winner chicken dinner?
Ok thanks
Based on what news Makk? Thanks
I am back in at $3.35. What's happening?
In at $33.41
Right now $273.37
Ok thanks
IDEX - What date was that article DJ? thanks
Yes it is.
$280.98. Not much to go on but in. LOL
I still entertain every morning and leave at 9:45 so I took a small gain and said bye bye. LOL But NICE that it got to over $6 I see as I just got home.
Out at $5.20
Ok welcome to America then BLRX. LOL
Ok let's do it.
Up 60% pre-market. That's "attention". LOL
Hang in there Pedro. Faith not fear.
BioLine Rx shares are trading higher after the company announced top-line results from its GENESIS Phase 3 trial of Motixafortide in stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.
BLRX - "exceptionally high level" of statistical significance. "These strikingly positive data significantly exceeded our expectations, and are truly transformational for our company," said Chief Executive Philip Serlin.
"exceptionally high level" of statistical significance. "These strikingly positive data significantly exceeded our expectations, and are truly transformational for our company," said Chief Executive Philip Serlin.